End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Insights provides the in-depth analysis of the pipeline assets across the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD). The main objective of this report to track competitor pipeline molecules, related research activities, technology, collaborations, in-licensing and out-licensing deals. The End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Report helps to identify emerging players with potentially strong product information and create effective counter-strategies to gain competitive advantage.

End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) - Pipeline Insights Report covers the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) pipeline molecules at various stages of development like Pre-registration phase, clinical phases (Phase III, Phase II & Phase I), pre-clinical and discovery phases. The Report also provides End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) related therapeutic assessments by molecule type, route of administration, monotherapy and combination products. The Report also highlights the discontinued and inactive projects in pipeline for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD).

Scope

- The report provides a End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) Landscape across the globe

- The report provides drug profiles which includes product description, MOA, licensors & collaborators, technology, development partner and chemical information

- Coverage of the End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) pipeline on the basis of target, MOA, route of administration, technology involved and molecule type

- The report reviews key players involved in the therapeutics development for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) and also provide company profiling

- Pipeline products coverage based on various stages of development from NDA filings to discovery.

- Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type

For more information visit http://www.researchandmarkets.com/research/kgq5kw/endstage_kidney

View source version on businesswire.com: http://www.businesswire.com/news/home/20150723005934/en/

Research and Markets
Laura Wood, Senior Manager
This e-mail address is being protected from spambots. You need JavaScript enabled to view it
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals

...